Latest Capital Efficiency News

OncoSil Medical has moved closer to local production after contract manufacturer Cyclotek secured ISO 13485 certification for its quality management system. Production at the Macquarie Park facility remains targeted for the end of 2Q FY27, subject to further regulatory approval.

Equus Energy has completed Pre-FEED on its large North West Shelf gas project and signed a conditional 10-year gas sales agreement with Alcoa. But the annual report also shows a $25 million loss, a $12 million rehabilitation provision and substantial funding and permitting hurdles before development can begin.

Impact Minerals’ 50%-owned Alluminous project reveals a strong financial case for a staged US high purity alumina plant, projecting a post-tax NPV₈ of A$518 million and a 42.3% IRR under a modular development approach.

Mader Group has initiated a $30 million on-market share buy-back, signalling confidence in its valuation and financial strength while maintaining its growth strategy.

Bayan Mining's patented ion-exchange technology demonstrated a 14-fold increase in yttrium concentration and a two-fold purity upgrade in independent bench-scale trials at the University of Queensland, highlighting commercial potential amid global supply disruptions.

WCM Global Growth Limited (ASX:WQG) has confirmed its fully franked final dividend for Q4 FY2026 at 2.35 cents per share, with a Dividend Reinvestment Plan (DRP) issue price capped by pre-tax net tangible assets per share.

Pentanet’s FY26 results reveal robust growth in cloud gaming and telco segments, with a 74% jump in EBITDA to $2.4 million and ongoing GPU expansion plans.

Vanadium Resources (ASX: VR8) has locked in a right of first refusal and exclusivity option over a prime brownfield site in South Africa’s Highveld Industrial Park for its planned V-Iron Plant, reinforcing its path towards feasibility and financing.

Vulcan Energy has unveiled a Preliminary Feasibility Study for Project Ludwig, its second lithium and geothermal phase in Germany, projecting stronger economics and a repeatable growth model.

Exultant Mining has kicked off fieldwork at Watsons Prospect and identified two additional priority copper-gold targets at its 390km² Black Hammer Project in the Macquarie Arc. The company is pursuing a staged exploration strategy while awaiting assay results from its maiden Balerion drill program.

Nexalis Therapeutics reports a 52% rise in half-year losses to $1.3 million amid funding facility cancellation and clinical trial suspensions, highlighting ongoing cash flow challenges.

Pivotal Metals’ latest metallurgical tests reveal copper recoveries exceeding 90% at the Horden Lake project, alongside robust recoveries of nickel, gold, silver, and palladium. These results underpin the upcoming scoping study and highlight the project’s financing potential through by-product credits.